期刊文献+

Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease 被引量:2

Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease
下载PDF
导出
摘要 瞄准:在 immunoproliferative 的诊断和预知评估 syndecan-1, bcl6 和 p53 的角色小肠的疾病(IPSID ) 并且学习 kappa (kappa ) 和人字缝尖(人字缝尖) 的侧面轻链和 IgA 重链。方法:学习由 IPSID 的 11 个盒子和包括了 11 正常肠粘膜和回肠的 11 高等级 B 房间淋巴瘤的控制的类似的数字组成了。分析的参数包括了临床的侧面,生物化学并且另外的实验室调查,放射线学并且组织检查所见包括免疫组织化学。结果:所有 IPSID 箱子有可论证的浆液 IgA 重链和重粘膜血浆房间渗入。根据 Galian 的组织学的阶段,有有舞台 A 的 4 个病人并且 7 与舞台 B。kappa 和人字缝尖轻链在 7 个病人是过去表示的;1 舞台 A H pylori 的耐心的有的 H pylori 积极的活跃胃炎和根除导致了疾病宽恕。舞台 A 活体检视为 syndecan-1 有更高的表示,当舞台 B 为 bcl6 和 p53 有更高的表示时。Syndecan-1, kappa 和人字缝尖轻链和 IgA 重链与 bcl6 和 p53 显示出反的关系。所有病人与 doxycycline 被对待。砍政体在得了坦率的淋巴瘤的 5 个病人被增加。三由于广泛的机关渗入死于疾病。结论:象 syndecan-1, kappa 和人字缝尖轻链和 IgA 重链一样的某些免疫标记能具有在识别早阶段 IPSID 的许多帮助。舞台 B IPSID 比上演 IPSID 为 bcl6 和 p53 显示出更高的表示。bcl6 和 p53 表情与一个更多的病沉重期舞台和好攻击的瘤行为相关。 AIM: To evaluate roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease (IPSID) and to study profiles of kappa (κ) and lambda (λ) light chains and IgA heavy chain. METHODS: The study consisted of 11 cases of IPSID and similar number of controls which included 11 of normal intestinal mucosa and 11 of high grade B cell lymphoma of ileum. The parameters analyzed included clinical profiles, biochemical and other laboratory investigations, radiologic and histological findings including immunohistochemistry. RESULTS: All IPSID cases had demonstrable serum IgA heavy chain and heavy mucosal plasma cell infiltration. According to Galian's histological staging, there were 4 patients with stage A and 7 with stage B. κ and ;λ light chains were over-expressed in 7 patients; 1 stage A patient had H pylori-positive active gastritis and eradication of H pylori led to disease remission. Stage A biopsies had higher expression for syndecan-1, while stage B had higher expression for bcl6 and p53. Syndecan-1,κ and λ light chains and IgA heavy chain showed inverse relationship with bcl6 and p53. All patients were treated with doxycycline. CHOP regime was added in 5 patients who developed frank lymphoma. Three died of the disease due to extensive organ infiltration. CONCLUSION: Certain immunomarkers like syndecan-1,κ and λ light chains and IgA heavy chain could be of much help in identifying early stage IPSID. Stage B IPSID showed higher expression for bcl6 and p53 than stage A IPSID. bcl6 and p53 expressions correlated with a more advanced disease stage and aggressive tumour behavior.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第22期3602-3608,共7页 世界胃肠病学杂志(英文版)
关键词 小肠疾病 病理机制 诊断 预防 BCL6 P53 IPSID Syndecan-1 bcl6 p53 protein κ and λ light chains Alpha heavy chain H pylori
  • 相关文献

参考文献49

  • 1[1]Seligmann M,Danon F,Hurez D,Mihaesco E,Preud'homme JL.Alpha-chain disease:a new immunoglobulin abnormality.Science 1968; 162:1396-1397
  • 2[2]Doe WF,Henry K,Hobbs JR,Jones FA,Dent CE,Booth CC.Five cases of alpha chain disease.Gut 1972; 13:947-957
  • 3[3]Seligmann M.Alpha chain disease:immunoglobulin abnormalities,pathogenesis and current concepts.Br J Cancer1975; 31 suppl 2:356-361
  • 4[4]Eidelman S.Abdominal lymphoma with malabsorption.JAMA 1974; 229:1103-1104
  • 5[5]Selzer G,Sherman G,Callihan TR,Schwartz Y.Primary small intestinal lymphomas and alpha-heavy-chain disease.A study of 43 cases from a pathology department in Israel.Isr J Med Sci1979; 15:111-123
  • 6[6]Seligmann M,Mihaesco E,Frangione B.Alpha chain disease.Ann N Y Acad Sci 1971; 190:487-500
  • 7[7]Tabbane F,Mourali N,Cammoun M,Najjar T.Results of laparotomy in immunoproliferative small intestinal disease.Cancer 1988; 61:1699-1706
  • 8[8]Ghoshal UC,Chetri K,Banerjee PK,Choudhuri G,Pal BB,Dabadghao S,Dhar K,Naik S,Naik SR.Is immunoproliferative small intestinal disease uncommon in India? Trop Gastroenterol 2001; 22:14-17
  • 9[9]Puri AS,Kumar M,Khan EM,Pandey R,Aggarwal R,Naik S,Choudhuri G,Naik SR.Immunoproliferative small intestinal disease:a frequently missed diagnosis.Indian J Gastroenterol 1996; 15:46-48
  • 10[10]Dhir V,Mohandas KM.Immunoproliferative small intestinal disease (IPSID):the Indian scenario.Indian J Gastroenterol 1997;16:38

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部